Spots Global Cancer Trial Database for vascular malformation
Every month we try and update this database with for vascular malformation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations | NCT06239480 | Microcystic Lym... | QTORIN 3.9% Rap... Placebo | 6 Years - | Palvella Therapeutics, Inc. | |
| A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations | NCT06239480 | Microcystic Lym... | QTORIN 3.9% Rap... Placebo | 6 Years - | Palvella Therapeutics, Inc. | |
| Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths | NCT00573729 | Port Wine Stain... | Pulsed Dye Lase... Pulsed Dye Lase... | 6 Months - | University of California, Irvine | |
| Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains | NCT00556946 | Port Wine Stain... | Combined Photod... | 18 Years - | University of California, Irvine | |
| Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths | NCT00573729 | Port Wine Stain... | Pulsed Dye Lase... Pulsed Dye Lase... | 6 Months - | University of California, Irvine | |
| A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations | NCT06239480 | Microcystic Lym... | QTORIN 3.9% Rap... Placebo | 6 Years - | Palvella Therapeutics, Inc. | |
| International Registry of Congenital Portosystemic Shunt (IRCPSS) | NCT06041906 | Congenital Port... | Shunt Closure | 1 Day - | University Hospital, Geneva | |
| Comprehensive HHT Outcomes Registry of the United States (CHORUS) | NCT06259292 | Hereditary Hemo... Arteriovenous M... Telangiectasia Epistaxis GastroIntestina... Cerebral Arteri... Vascular Malfor... | - | Cure HHT | ||
| Bioseal Dural Sealing Study BIOS-14-001 | NCT03110783 | Benign Tumors Malignant Tumor... Vascular Malfor... | Bioseal | 18 Years - | Guangzhou Bioseal Biotechnology Co., Ltd. | |
| MiDura-Study (Neuro-Patch in Duraplasty) | NCT04189172 | Meningioma Tumor, Brain Chiari Malforma... Vascular Malfor... Hydrocephalus Tethered Cord Dural Fistula Craniotomy Spinal Surgery Duraplasty | 18 Years - | Aesculap AG | ||
| Comprehensive HHT Outcomes Registry of the United States (CHORUS) | NCT06259292 | Hereditary Hemo... Arteriovenous M... Telangiectasia Epistaxis GastroIntestina... Cerebral Arteri... Vascular Malfor... | - | Cure HHT | ||
| International Registry of Congenital Portosystemic Shunt (IRCPSS) | NCT06041906 | Congenital Port... | Shunt Closure | 1 Day - | University Hospital, Geneva |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
